Why Is Wave Life Sciences Stock Falling After Weight Loss Study Data?

All NewsMarch 26, 2026

Wave Life Sciences stock drops after INLIGHT Phase 1 data. WVE-007 shows fat reduction, lean mass stability, and biomarker suppression.

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent